Clinical Trials Directory

Trials / Completed

CompletedNCT01972204

Intensive Instruction on the Use of Aricept

A Study About the Impact of Intensive Instruction on the Use of Aricept and the Reasons for Discontinuation in Patients With Alzheimer's Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
125 (actual)
Sponsor
Mirai Iryo Research Center, Inc. · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the influence of the instruction on the use of Aricept with educational brochure on the 48-week medication persistence and to assess the reasons for discontinuation.

Detailed description

To examine the influence of the instruction on the use of Aricept with educational brochure comparing to the ordinary instruction on the 48-week medication persistence and to assess the reasons for discontinuation.

Conditions

Interventions

TypeNameDescription
BEHAVIORALIntensive adherence instructionInstruction with educational brochure
BEHAVIORALControlInstruction as per usual practice

Timeline

Start date
2013-09-01
Primary completion
2017-08-01
Completion
2017-08-01
First posted
2013-10-30
Last updated
2019-06-03
Results posted
2019-06-03

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT01972204. Inclusion in this directory is not an endorsement.